NCT05455437View on ClinicalTrials.gov

Monitoring and Evaluation Study of Project ECHO for ILD

UnknownOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions

Interstitial Lung Diseases

Trial Locations (1)

02130

Pulmonary Care and Research Collaborative, Ltd., Boston

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Pulmonary Care and Research Collaborative Limited

OTHER

NCT05455437 - Monitoring and Evaluation Study of Project ECHO for ILD | Biotech Hunter | Biotech Hunter